Literature DB >> 27217413

Pilot Study of Blood Pressure in Girls With Turner Syndrome: An Awareness Gap, Clinical Associations, and New Hypotheses.

Evan Los1, Emilio Quezada2, Zunqiu Chen2, Jodi Lapidus2, Michael Silberbach2.   

Abstract

Cardiovascular disease is the major factor that reduces lifespan in Turner syndrome. High blood pressure (BP) is common in Turner syndrome and is the most easily treatable cardiovascular risk factor. We studied the prevalence of elevated screening systemic BP, awareness of the problem, and its clinical associations in a large group of girls attending the annual meeting of the Turner Syndrome Society of the United States. Among 168 girls aged 2 to 17 years, 42% had elevated screening BP (systolic and diastolic), yet only 8% reported a previous diagnosis of hypertension. History of aortic coarctation repair (17%) was positively associated with elevated systolic BP (52% versus 32%; P<0.05). Elevated systolic BP was positively associated with obesity (56% versus 31%; P<0.05). Because the prevalence of obesity in the studied population was similar to Center for Disease Control published data for obesity in all girls and the prevalence of increased BP is approximately twice that of the general population, the Turner syndrome phenotype/genotype probably includes an intrinsic risk for hypertension. Obesity and repaired aortic coarctation increase this risk further. There seems to be a BP awareness gap in girls with Turner syndrome. Because girls living with Turner syndrome are a sensitized population for hypertension, further study may provide clues to genetic factors leading to a better understanding of essential hypertension in the general population.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  Turner syndrome; aortic coarctation; high blood pressure; hypertension; obesity

Mesh:

Year:  2016        PMID: 27217413     DOI: 10.1161/HYPERTENSIONAHA.115.07065

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS).

Authors:  Ramya Sivasubramanian; Kevin E Meyers
Journal:  Curr Hypertens Rep       Date:  2021-03-29       Impact factor: 5.369

2.  Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol).

Authors:  Elodie Fiot; Bertille Alauze; Bruno Donadille; Dinane Samara-Boustani; Muriel Houang; Gianpaolo De Filippo; Anne Bachelot; Clemence Delcour; Constance Beyler; Emilie Bois; Emmanuelle Bourrat; Emmanuel Bui Quoc; Nathalie Bourcigaux; Catherine Chaussain; Ariel Cohen; Martine Cohen-Solal; Sabrina Da Costa; Claire Dossier; Stephane Ederhy; Monique Elmaleh; Laurence Iserin; Hélène Lengliné; Armelle Poujol-Robert; Dominique Roulot; Jerome Viala; Frederique Albarel; Elise Bismuth; Valérie Bernard; Claire Bouvattier; Aude Brac; Patricia Bretones; Nathalie Chabbert-Buffet; Philippe Chanson; Regis Coutant; Marguerite de Warren; Béatrice Demaret; Lise Duranteau; Florence Eustache; Lydie Gautheret; Georges Gelwane; Claire Gourbesville; Mickaël Grynberg; Karinne Gueniche; Carina Jorgensen; Veronique Kerlan; Charlotte Lebrun; Christine Lefevre; Françoise Lorenzini; Sylvie Manouvrier; Catherine Pienkowski; Rachel Reynaud; Yves Reznik; Jean-Pierre Siffroi; Anne-Claude Tabet; Maithé Tauber; Vanessa Vautier; Igor Tauveron; Sebastien Wambre; Delphine Zenaty; Irène Netchine; Michel Polak; Philippe Touraine; Jean-Claude Carel; Sophie Christin-Maitre; Juliane Léger
Journal:  Orphanet J Rare Dis       Date:  2022-07-12       Impact factor: 4.303

3.  The Cutoff of Gonadotropins for Close Evaluation of Cardiometabolic Risk Factors in Turner Syndrome.

Authors:  Shahin Koohmanaee; Behrang Motamed; Sharareh Ghorbandoust; Hamidreza Badeli; Afagh Hassanzadeh Rad; Setila Dalili; Zohre Darabipour
Journal:  Int J Prev Med       Date:  2022-04-08

4.  The Natural History of Metabolic Comorbidities in Turner Syndrome from Childhood to Early Adulthood: Comparison between 45,X Monosomy and Other Karyotypes.

Authors:  Yael Lebenthal; Sigal Levy; Efrat Sofrin-Drucker; Nessia Nagelberg; Naomi Weintrob; Shlomit Shalitin; Liat de Vries; Ariel Tenenbaum; Moshe Phillip; Liora Lazar
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-09       Impact factor: 5.555

Review 5.  Pheochromocytoma as a rare cause of hypertension in a 46 X, i(X)(q10) turner syndrome: a case report and literature review.

Authors:  Ji Yeon Shin; Bo Hyun Kim; Young Keum Kim; Tae Hwa Kim; Eun Heui Kim; Min Jin Lee; Jong Ho Kim; Yun Kyung Jeon; Sang Soo Kim; In Joo Kim
Journal:  BMC Endocr Disord       Date:  2018-05-10       Impact factor: 2.763

6.  Cardiac abnormalities in girls with Turner syndrome: ECG abnormalities, myocardial strain imaging, and karyotype-phenotype associations.

Authors:  Iris D Noordman; Zina Fejzic; Melanie Bos; Anthonie L Duijnhouwer; Gert Weijers; Marlies Kempers; Remy Merkx; Janiëlle A E M van der Velden; Livia Kapusta
Journal:  Am J Med Genet A       Date:  2021-05-10       Impact factor: 2.802

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.